InvestorsHub Logo
Followers 5
Posts 1086
Boards Moderated 0
Alias Born 12/04/2018

Re: Ecomike post# 1218

Friday, 04/26/2024 2:42:18 PM

Friday, April 26, 2024 2:42:18 PM

Post# of 1246
It puzzles and dismays me that a patient-friendly non injectable remedy for common metabolic disorders hasn't yet attracted funding or transformed Bioxytran into a viable takeover target by, say, Merck, Monsanto or J&J, et al...I'm long on BIXT and will empty the bank for it if other stocks I'm waiting on come through in a timely manner...
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIXT News